Magnetically controlling release of drug involves applying composite coating with magnetic nanoparticles of zinc oxide-manganese oxide-iron oxide to implant, placing implant in body, and impacting device and release of active substance
	KRITSKAYA E A; PYATAKOV A P; VYLEGZHANIN A G
	2018-07-12
专利权人	SHEL LLC (SHEL-Non-standard)
申请日期	2018-07-12
专利号	RU2018125759-A
成果简介	NOVELTY - Magnetically controlling the release of drug, comprises applying a composite coating with magnetic nanoparticles of zinc oxide-manganese oxide-iron oxide (ZnO.1MnO.9Fe2O4) to an implant in a film of the thermosensitive polymer poly(N-isopropylacrylamide), placing the implant in the patient's body, and impacting the implanted device and the subsequent release of the active substance by controlling the reversible phase transition between the hydrophobic and hydrophilic states using an alternating magnetic field (at amplitude of 100 Oe, 100 kHz). USE - The method is useful for magnetically controlling the release of drug.
IPC 分类号	A61K-009/00
国家	俄罗斯
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/23344
专题	中国科学院新疆生态与地理研究所
作者单位	SHEL LLC (SHEL-Non-standard)
推荐引用方式 GB/T 7714	KRITSKAYA E A,PYATAKOV A P,VYLEGZHANIN A G. Magnetically controlling release of drug involves applying composite coating with magnetic nanoparticles of zinc oxide-manganese oxide-iron oxide to implant, placing implant in body, and impacting device and release of active substance. RU2018125759-A[P]. 2018.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。